Evidence map›Paper›PMID 38790330›Full record

ArticleBioengineering (Basel, Switzerland)2024

MurSS: A Multi-Resolution Selective Segmentation Model for Breast Cancer.

Joonho Lee, Geongyu Lee, Tae-Yeong Kwak, Sun Woo Kim, Min-Sun Jin, Chungyeul Kim, Hyeyoon Chang

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joonho LeeDeep Bio Inc., Seoul 08380, Republic of Korea.ORCID 0009-0007-8963-2117
Geongyu LeeDeep Bio Inc., Seoul 08380, Republic of Korea.ORCID 0000-0002-9946-4352
Tae-Yeong KwakDeep Bio Inc., Seoul 08380, Republic of Korea.ORCID 0000-0001-9171-7258
Sun Woo KimDeep Bio Inc., Seoul 08380, Republic of Korea.
Min-Sun JinDepartment of Pathology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 14647, Republic of Korea.ORCID 0000-0001-8412-3363
Chungyeul KimDepartment of Pathology, Korea University Guro Hospital, Seoul 08308, Republic of Korea.
Hyeyoon ChangDeep Bio Inc., Seoul 08380, Republic of Korea.ORCID 0000-0002-4274-4652

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurately segmenting cancer lesions is essential for effective personalized treatment and enhanced patient outcomes. We propose a multi-resolution selective segmentation (MurSS) model to accurately segment breast cancer lesions from hematoxylin and eosin (H&E) stained whole-slide images (WSIs). We used The Cancer Genome Atlas breast invasive carcinoma (BRCA) public dataset for training and validation. We used the Korea University Medical Center, Guro Hospital, BRCA dataset for the final test evaluation. MurSS utilizes both low- and high-resolution patches to leverage multi-resolution features using adaptive instance normalization. This enhances segmentation performance while employing a selective segmentation method to automatically reject ambiguous tissue regions, ensuring stable training. MurSS rejects 5% of WSI regions and achieves a pixel-level accuracy of 96.88% (95% confidence interval (CI): 95.97-97.62%) and mean Intersection over Union of 0.7283 (95% CI: 0.6865-0.7640). In our study, MurSS exhibits superior performance over other deep learning models, showcasing its ability to reject ambiguous areas identified by expert annotations while using multi-resolution inputs.

Indexed as

breast cancermulti-resolutionsegmentationselective segmentation method

Identifiers

PMID38790330
PMCPMC11117971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.